No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes.
Diabetologia
; 54(10): 2736-8, 2011 Oct.
Article
in En
| MEDLINE
| ID: mdl-21822789
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glyburide
/
Potassium Channels, Inwardly Rectifying
/
Diabetes Mellitus
Type of study:
Risk_factors_studies
Limits:
Humans
/
Newborn
Language:
En
Journal:
Diabetologia
Year:
2011
Document type:
Article